| 1 |
34958116 | Inhibition of triple‑negative breast cancer proliferation and motility by reactivating p53 and inhibiting overactivated Akt. | 2022 Feb |
1 |
| 2 |
35167193 | ARID1A-deficient cells require HDAC6 for progression of endometrial carcinoma. | 2022 Jun |
2 |
| 3 |
35614130 | Acetylation licenses Th1 cell polarization to constrain Listeria monocytogenes infection. | 2022 May 25 |
1 |
| 4 |
33883923 | Histone Deacetylase 6 Regulates the Activation of M1 Macrophages by the Glycolytic Pathway During Acute Liver Failure. | 2021 |
1 |
| 5 |
34180140 | HDAC6 inhibitor ACY1215 inhibits the activation of NLRP3 inflammasome in acute liver failure by regulating the ATM/F-actin signalling pathway. | 2021 Aug |
1 |
| 6 |
31390677 | Histone deacetylase 6 promotes growth of glioblastoma through the MKK7/JNK/c-Jun signaling pathway. | 2020 Jan |
2 |
| 7 |
32435850 | Selective targeting of different populations of myeloid-derived suppressor cells by histone deacetylase inhibitors. | 2020 Sep |
1 |
| 8 |
32572875 | Histone deacetylase 6 inhibitor ACY1215 ameliorates mitochondrial dynamic and function injury in hepatocytes by activating AMPK signaling pathway in acute liver failure mice. | 2020 Sep |
3 |
| 9 |
32705192 | ACY‑1215, a HDAC6 inhibitor, decreases the dexamethasone‑induced suppression of osteogenesis in MC3T3‑E1 cells. | 2020 Sep |
1 |
| 10 |
33103445 | Histone deacetylase 6 inhibition mitigates renal fibrosis by suppressing TGF-β and EGFR signaling pathways in obstructive nephropathy. | 2020 Dec 1 |
1 |
| 11 |
30664664 | Functional cooperativity of p97 and histone deacetylase 6 in mediating DNA repair in mantle cell lymphoma cells. | 2019 Jul |
1 |
| 12 |
31244662 | Quantitative Proteomic Analysis Reveals the Sites Related to Acetylation and Mechanism of ACY-1215 in Acute Liver Failure Mice. | 2019 |
2 |
| 13 |
31311810 | HDAC6 Inhibition Synergizes with Anti-PD-L1 Therapy in ARID1A-Inactivated Ovarian Cancer. | 2019 Nov 1 |
1 |
| 14 |
31356453 | Cell-specific role of histone deacetylase 6 in chemotherapy-induced mechanical allodynia and loss of intraepidermal nerve fibers. | 2019 Dec |
1 |
| 15 |
31571096 | Protective Effects of ACY-1215 Against Chemotherapy-Related Cognitive Impairment and Brain Damage in Mice. | 2019 Nov |
3 |
| 16 |
31634464 | Histone deacetylase 6 inhibitor ACY1215 offers a protective effect through the autophagy pathway in acute liver failure. | 2019 Dec 1 |
3 |
| 17 |
29112935 | Histone deacetylase 6 inhibitor ACY-1215 protects against experimental acute liver failure by regulating the TLR4-MAPK/NF-κB pathway. | 2018 Jan |
2 |
| 18 |
29760044 | NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model. | 2018 Jul 1 |
1 |
| 19 |
30043566 | ACY 1215, a histone deacetylase 6 inhibitor, inhibits cancer cell growth in melanoma. | 2018 Jul-Aug |
3 |
| 20 |
30050135 | Ricolinostat (ACY-1215) suppresses proliferation and promotes apoptosis in esophageal squamous cell carcinoma via miR-30d/PI3K/AKT/mTOR and ERK pathways. | 2018 Jul 26 |
2 |
| 21 |
27957719 | Development of Improved HDAC6 Inhibitors as Pharmacological Therapy for Axonal Charcot-Marie-Tooth Disease. | 2017 Apr |
1 |
| 22 |
28267067 | HDAC6 inhibition effectively reverses chemotherapy-induced peripheral neuropathy. | 2017 Jun |
2 |
| 23 |
28747357 | An inhibitor of histone deacetylase 6 activity, ACY-1215, reduces cAMP and cyst growth in polycystic kidney disease. | 2017 Oct 1 |
1 |
| 24 |
25458911 | Histone deacetylase 6 inhibition impairs effector CD8 T-cell functions during skin inflammation. | 2015 May |
1 |
| 25 |
26116270 | Dual Targeting of Protein Degradation Pathways with the Selective HDAC6 Inhibitor ACY-1215 and Bortezomib Is Synergistic in Lymphoma. | 2015 Oct 15 |
2 |